Therapy with ombitasvir/paritaprevir/ritonavir plus dasabuvir is effective and safe for the treatment of genotypes 1 and 4 hepatitis C virus (HCV) infection in patients with severe renal impairment: A multicentre experience

1. Muñoz-Gómez, R.
2. Rincón, D.
3. Ahumada, A.
4. Hernández, E.
5. Devesa, M.J.
6. Izquierdo, S.
7. Ortiz, M.
8. Hernández-Albujar, A.
9. Fernández-Rodríguez, C.
10. Calvo, M.
11. González, R.
12. Lozano, M.
13. Castellano, G.
14. Fernández-Vázquez, I.